Michael J. Fox Inspired Portrayal of Parkinson's Disease

ASN-90 is under clinical development by Asceneuron and currently in Phase I for Parkinson’s Disease. According to GlobalData, Phase I drugs for Parkinson’s Disease have a 72% phase transition success ...
A new study found that Parkinson's disease patients who took dance classes experienced fewer symptoms of depression, with ...
Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the benefits can be seen in multiple ways, a new study ... Nov. 19, 2024 — A recently published study ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
"Parkinson's disease doesn't have to just be this disease of diminishing, but it's of new ways to move and be creating ...
Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. © 2024 ...
Mental health symptoms of Parkinson's include mild memory and thinking problems, anxiety, dementia, depression, ...
Qatar University (QU), in partnership with the International Parkinson and Movement Disorder Society (MDS), has successfully concluded ...
One such debilitating and devastating condition is called Parkinson’s disease - a degenerative disorder that affects the brain and the central nervous system. Often this condition affects the ...
A condition that affects thousands can be detected decades before diagnosis. Parkinson's disease, a progressive disorder of ...